retatrutide study near me A new clinical trial from Eli Lilly and Company suggests its experimental triple hormone drug, retatrutide, could become one of the next major medications in the rapidly growing weight loss and diabetes A Study of Retatrutide (LY3437943)

Heres what the science shows and what this means for your weight loss journey

By the Peptigo Research Team Published April 2026 Last reviewed April 23, 2026 15 minute read The incretin pharmacology field has moved faster in the past decade than at any point in its history

At 4mg, meal timing becomes important

Without resistance training and protein optimization, expect approximately 31-38% of total weight lost to come from lean mass

What happens if I stop taking Retatrutide

By adding Sermorelin to a Retatrutide protocol, researchers aim to shift the ratio of fat to muscle lost, preserving more metabolically active tissue throughout the weight loss phase